These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1982662)

  • 1. Treatment of acid-related disorders with gastric acid inhibitors: the state of the art.
    Blum AL
    Digestion; 1990; 47 Suppl 1():3-10; discussion 49-52. PubMed ID: 1982662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D; Buckley MM; Heel RC
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical development programme for omeprazole.
    Walan A
    Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
    Asaki S; Kimpara T; Ohara S; Hongo M
    Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.
    Tytgat GN; Lamers CB; Hameeteman W; Jansen JM; Wilson JA
    Aliment Pharmacol Ther; 1987 Feb; 1(1):31-8. PubMed ID: 2908747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility and safety of omeprazole.
    Walan A
    Scand J Gastroenterol Suppl; 1989; 166():140-4; discussion 145. PubMed ID: 2574908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory peptic ulcers.
    Arakawa T; Kobayashi K; Dajani EZ
    J Assoc Acad Minor Phys; 1992; 3(3):95-102. PubMed ID: 1386767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relapse of peptic ulcer after quick healing induced by proton pump inhibitors].
    Tsukamoto Y; Niwa Y; Arisawa T
    Nihon Rinsho; 1992 Jan; 50(1):174-80. PubMed ID: 1371814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole in the treatment of peptic ulcers resistant to H2-receptor antagonists.
    Guerreiro AS; Neves BC; Quina MG
    Aliment Pharmacol Ther; 1990 Jun; 4(3):309-13. PubMed ID: 1983325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 17. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW; Lamers CB
    Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
    [No Abstract]   [Full Text] [Related]  

  • 19. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
    Yukawa K; Yukawa E
    Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.